Thursday, September 10, 2009 3:06:07 PM
Here you go in black and white.This will be at 50 to 60 minimum near the open.With even 1 or 2 good months you will see 1 or 2 dollars.In fact you may see this at 1.00 dollar by open.
There is no mortage point one.
Second everything is paid for or will be paid for.
Thrid if you REREAD the PR you will see that company still had a few shares to sell.
They wanted to have cash on hand.
With the money presently in the bank, it will be able to pay all debts owed to vendors, and equipment suppliers, and open with enough money to maintain a high level of play. The company also plans to have adequate reserve capital in the bank. Seldom does a company open in this position, and we thought our stockholders would like to know.
The adequate reserve captial translate to we need to sell a few shares still but the majority has been covered.
So not only are they going to open debt free but they are smart enough to have cash on hand just in case.
To me anyway its a smart game plan.
I do the same in my business's always have cash on hand for emergency's and to maintain the business.
If you dont need the cash you just let it sit in the bank.
Peace Out
There is no mortage point one.
Second everything is paid for or will be paid for.
Thrid if you REREAD the PR you will see that company still had a few shares to sell.
They wanted to have cash on hand.
With the money presently in the bank, it will be able to pay all debts owed to vendors, and equipment suppliers, and open with enough money to maintain a high level of play. The company also plans to have adequate reserve capital in the bank. Seldom does a company open in this position, and we thought our stockholders would like to know.
The adequate reserve captial translate to we need to sell a few shares still but the majority has been covered.
So not only are they going to open debt free but they are smart enough to have cash on hand just in case.
To me anyway its a smart game plan.
I do the same in my business's always have cash on hand for emergency's and to maintain the business.
If you dont need the cash you just let it sit in the bank.
Peace Out
Recent BSEM News
- BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/31/2026 08:05:00 PM
- BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025 • GlobeNewswire Inc. • 03/30/2026 11:00:00 AM
- BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 03/24/2026 08:05:00 PM
- BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair • GlobeNewswire Inc. • 03/23/2026 03:40:56 PM
- BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair • GlobeNewswire Inc. • 03/23/2026 11:00:00 AM
- BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026 • GlobeNewswire Inc. • 03/11/2026 08:05:00 PM
- BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference • GlobeNewswire Inc. • 02/20/2026 12:00:00 PM
- BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research • GlobeNewswire Inc. • 02/03/2026 09:05:00 PM
- BioStem Technologies Advances Entry into the Acute Wound Care Market with Acquisition of BioTissue Holdings’ Surgical and Wound Care Business • GlobeNewswire Inc. • 01/21/2026 10:30:00 PM
- BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes • GlobeNewswire Inc. • 01/07/2026 09:05:00 PM
- BioStem Technologies Products Placed on “12-Month Status Quo Period” List in Update to CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes • GlobeNewswire Inc. • 12/18/2025 12:00:00 PM
- BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference • GlobeNewswire Inc. • 12/10/2025 12:00:00 PM
- BioStem Technologies Expands Product Access in Medicaid • GlobeNewswire Inc. • 11/25/2025 01:59:13 PM
- BioStem Technologies Reports Third Quarter 2025 Financial Results • GlobeNewswire Inc. • 11/13/2025 09:02:00 PM
- BioStem Technologies Announces Filing of Restated Financial Statements • GlobeNewswire Inc. • 11/13/2025 09:01:00 PM
- BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes • GlobeNewswire Inc. • 11/05/2025 09:05:00 PM
- BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters • GlobeNewswire Inc. • 11/05/2025 12:00:00 PM
- BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers • GlobeNewswire Inc. • 10/31/2025 11:00:00 AM
- BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025 • GlobeNewswire Inc. • 10/30/2025 08:05:00 PM
- BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant • GlobeNewswire Inc. • 10/27/2025 08:15:00 PM
- BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program • GlobeNewswire Inc. • 10/02/2025 04:00:00 PM
